India, Feb. 10 -- The Economic Times recently published a story claiming that Ajanta Pharma's promoters are planning to raise Rs2,000 crore to buy a controlling stake in Restaurant Brands Asia, which operates Burger King outlets in India and Indonesia. The report suggested this would be the pharmaceutical company's entry into the fast-food business.

According to the article, the money would come from a mix of personal loans to promoters and company-level debt. Banks like Barclays and Standard Chartered were reportedly being approached for funding, though nothing had been finalised.

The Bigger Picture Restaurant Brands Asia is valued at roughly Rs3,800 crore in the stock market. Private equity firm Everstone Capital, which owns 11.26% of...